Policies & Publications: Clinical Governance

Title Document Number Last Reviewed
Assessment and Management of Serious Incidents SESLHDPR/549
Caring for COVID positive patients in the community SESLHDPR/721
Clinical Handover: Implementation of ISBAR Framework and Key Standard Principles SESLHDPR/303
Clinical Pathway Guideline SESLHDGL/037
Companion and Assistance Animals in Healthcare Facilities SESLHDPR/590
Complaint Handling Framework SESLHDHB/026
Death Screening and Review SESLHDGL/071
Framework for Governance of Policy Documents in SESLHD SESLHDHB/019
Governance of Powered Air-Purifying Respirators (PAPRs) or Elastomeric Respirators SESLHDPR/688
Infection Prevention and Control during construction, renovation or maintenance SESLHDPR/374
Management of Complex Discharges / Escalation Guidelines SESLHDGL/053
Management of Deteriorating PAEDIATRIC Inpatient SESLHDPR/284
Management of the Deteriorating ADULT inpatient (excluding maternity) SESLHDPR/697
Management of the deteriorating MATERNITY woman SESLHDPR/705
Management of the Deteriorating NEONATAL Inpatient SESLHDPR/340
Managing Complaints and Concerns about Clinicians (MCCC) SESLHDPR/640
Maternity – identifying, reviewing and reporting trigger and critical clinical events SESLHDGL/095
Medical Discharge Summary Completion Standards SESLHDPR/223
Medicine: Management of Refrigerated Storage of Medicines and Vaccinations in Clinical Areas SESLHDPR/300
New or altered interventional procedures, technologies including devices, implants, point of care (POC) diagnostic machines or treatments – safe introduction into clinical practice SESLHDPD/286
Open Disclosure SESLHDGL/058
Paediatric Policies - Use in SESLHD SESLHDGL/064
Photography and Recording of Patients within the SESLHD SESLHDPD/327
Post Incident Bedside Safety Huddles and effective use of the HUDDLE UP tool SESLHDGL/072
Procedure for SESLHD facility visitors in home isolation or quarantine for COVID-19 exposure with exemption under compassionate grounds

SESLHDPR/682
Product – Clinical Product Notices, Recalls and Safety Alerts SESLHDPR/319
Reporting of Clinical Product Faults/Quality Issues SESLHDPR/419
Reporting of notifiable Adverse Events Following Immunisation (AEFI) – local reporting process for COVID-19 Vaccination SESLHDBR/096
SAER Recommendations Compliance Monitoring SESLHDPR/320
Standard 5 Comprehensive Care - Guideline SESLHDGL/088